Telomere lengthening in telomerase-negative cells: the ends are coming together

被引:22
作者
Scheel, C [1 ]
Poremba, C [1 ]
机构
[1] Univ Munster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany
关键词
telomeres; telomerase; ALT; cancer;
D O I
10.1007/s00428-002-0634-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Telomeres are crucial for chromosomal stability and cell viability. Activation of telomerase, a specialized reverse transcriptase, is the predominant mechanism for maintaining telomere length and function in yeasts and human cells. Telomere maintenance is regarded as a key element in the immortalization of cells and hence in oncogenesis. Although more than 90% of all malignant tumors display telomerase activity, there appear to be alternatives to this mechanism. Alternative lengthening of telomeres (ALT) in the absence of telomerase has been described in various organisms and recently also in immortalized and transformed human cells. This article will discuss how ALT is detected and how it affects telomere morphology. It will review the frequency and relevance of ALT in in vitro immortalized cell lines, tumor-derived cell lines, and primary tumors. We have only begun to link mechanisms by means of which ALT may act in immortalized human cells to the growing knowledge about telomeres, and we can look forward to further fascinating insights into telomere biology. Our review will also emphasize recent advances in our understanding of the induction and repression of ALT and the demonstration of ALT in cancer cells in the light of new treatment strategies targeted against telomere maintenance mechanisms.
引用
收藏
页码:573 / 582
页数:10
相关论文
共 72 条
[1]   Telomere maintenance mechanisms as a target for drug development [J].
Bearss, DJ ;
Hurley, LH ;
Von Hoff, DD .
ONCOGENE, 2000, 19 (56) :6632-6641
[2]   Switching and signaling at the telomere [J].
Blackburn, EH .
CELL, 2001, 106 (06) :661-673
[3]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[4]  
BROCCOLI D, 1993, AM J HUM GENET, V52, P657
[5]   The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit [J].
Bryan, TM ;
Marusic, L ;
Bacchetti, S ;
Namba, M ;
Reddel, RR .
HUMAN MOLECULAR GENETICS, 1997, 6 (06) :921-926
[6]   TELOMERE ELONGATION IN IMMORTAL HUMAN-CELLS WITHOUT DETECTABLE TELOMERASE ACTIVITY [J].
BRYAN, TM ;
ENGLEZOU, A ;
GUPTA, J ;
BACCHETTI, S ;
REDDEL, RR .
EMBO JOURNAL, 1995, 14 (17) :4240-4248
[7]   Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines [J].
Bryan, TM ;
Englezou, A ;
DallaPozza, L ;
Dunham, MA ;
Reddel, RR .
NATURE MEDICINE, 1997, 3 (11) :1271-1274
[8]   Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo [J].
Cabuy, E ;
de Ridder, L .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 2001, 439 (02) :176-184
[9]   Telomere maintenance by telomerase and by recombination can coexist in human cells [J].
Cerone, MA ;
Londono-Vallejo, JA ;
Bacchetti, S .
HUMAN MOLECULAR GENETICS, 2001, 10 (18) :1945-1952
[10]   The hTERTα splice variant is a dominant negative inhibitor of telomerase activity [J].
Colgin, LM ;
Wilkinson, C ;
Englezou, A ;
Kilian, A ;
Robinson, MO ;
Reddel, RR .
NEOPLASIA, 2000, 2 (05) :426-432